How is the Mannkind Corp today?

The Mannkind Corp today is trading in the down by -0.27% at 3.76.

How has Mannkind Corp performed historically?

The Mannkind Corp is currently trading down -0.27% on an intraday basis in the past week the index fell -0.27%. The index has been down -26.27% in the past quarter and fell -28.92% in the past year. You can view this in the overview section.

What is Mannkind Corp Annual Revenue?

Mannkind Corp Annual Revenue rose 43.5%, in the last year to $285.5 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Mannkind Corp Annual Net Profit?

Mannkind Corp Annual Net Profit rose 331.09% in the last year to $27.59 M. Its sector's average net profit growth for the last fiscal year was -14.06%.

What is Mannkind Corp Price to Earning Ratio?

Mannkind Corp Price to Earning Ratio is 37.95, higher than its sector PE ratio of 4.57.

What is Mannkind Corp Stock Price?

Mannkind Corp Stock Price fell 28.92% and underperformed its sector by 63.79% in the past year.

What is Mannkind Corp Quarterly Revenue?

Mannkind Corp Quarterly Revenue rose 18.25% YoY to $78.35 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Mannkind Corp Quarterly Net profit?

Mannkind Corp Quarterly Net profit rose 23.78% YoY to $13.16 M. Its sector's average net profit growth YoY for the quarter was -235.94%.

What is Mannkind Corp Mutual Fund Holding?

Mannkind Corp Mutual Fund Holding decreased by 0.22% in the last quarter to 30.89.

What is Mannkind Corp Promoter Share Holding?

Mannkind Corp Promoter Share Holding increased by 0.39% in the most recent quarter to 4.36%.

What is Mannkind Corp Interest Coverage Ratio?

Mannkind Corp Interest Coverage Ratio is 1.8, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Mannkind Corp Institutional Holding?

Mannkind Corp Institutional Holding remained the same in the last quarter at 59.01%.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : MAJOR PHARMACEUTICALS
MANNKIND CORP

Mannkind Corp XNAS: MNKD

Mannkind Corp Live Share Price Today, Share Analysis and Chart

Name: Mannkind Corp: Is Infosys Ltd. worth buying?
Item: Mannkind Corp
Rating: 1.42150
Author: Trendlyne DVM scores

about

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin huma...

3.76 -0.01 (-0.27%)

Near 52W Low of $3.63

9.5M

XNAS Volume

High volume today

XNAS 27 Jun, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

23.0 / 100

Technically Bearish

33.9 / 100

1Yr Price target upside is 151%

7 analysts

Mannkind Corp Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Mannkind Corp Live Share Price Today, Share Analysis and Chart

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin huma...

Near 52W Low of $3.63

High volume today

SWOT Analysis

Mannkind Corp Live Price Chart

Mannkind Corp FAQ

How is Mannkind Corp today?

Mannkind Corp today is trading in the red, and is down by -0.27% at 3.76.

How has Mannkind Corp performed historically?

Mannkind Corp is currently trading down -0.27% on an intraday basis. In the past week the stock fell -0.27%. stock has been down -26.27% in the past quarter and fell -28.92% in the past year. You can view this in the overview section.